Skip to main content
logo
Microba Life Sciences Limited (ASX:MAP)
Australia flag Australia · Delayed Price · Currency is AUD
0.0530
0.00 (0.00%)
Sep 17, 2026, 9:59 AM AEST

Microba Life Sciences Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
14.7614.7615.6712.095.424.69
Revenue Growth
-0.98%-5.81%29.60%123.06%15.60%25.62%
Gross Profit
7.037.037.445.912.682.37
Operating Income
-20.3-20.3-24.61-25.84-20.23-16.27
Net Income
-20.72-20.72-14.94-19.94-12.68-11.47
Earnings Per Share
-0.03-0.03-0.03-0.05-0.04-0.05
EPS Growth
------

Revenue by Segment
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Research & Development
0.040.04----
Testing Services and Supplements
14.7214.7215.6712.095.424.69
Total
14.7614.7615.6712.095.424.69

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
7.957.9511.7421.0932.2530.79
Total Debt
4.114.113.231.581.141.33
Net Cash (Debt)
3.843.848.5119.5131.1129.46
Net Cash Growth
-56.01%-54.85%-56.40%-37.28%5.60%130.88%
Net Cash Per Share
0.010.010.020.050.100.13

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-12.37-12.37-12.01-15.57-12.39-10.45
Capital Expenditures
-0.24-0.24-0.33-1.49-0.55-1.64
Free Cash Flow
-12.61-12.61-12.34-17.05-12.94-12.08
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
47.61%47.61%47.49%48.84%49.41%50.46%
Operating Margin
-137.58%-137.58%-157.05%-213.71%-373.24%-347.05%
Pretax Margin
-142.18%-142.18%-96.02%-165.34%-233.84%-244.45%
Profit Margin
-140.40%-140.40%-95.34%-164.92%-233.95%-244.64%
FCF Margin
-85.45%-85.45%-78.75%-141.06%-238.82%-257.75%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
2.511.712.795.9319.0511.70